Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
0.7650
-0.0110 (-1.42%)
Nov 25, 2025, 4:00 PM EST
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $270.64 million as of November 25, 2025. Its market cap has decreased by -26.83% in one year.
Market Cap
270.64M
Enterprise Value
712.06M
Revenue
661.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.76
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 270.64M, a decrease of -56.89%. That is a compound annual growth rate of -11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 270.64M | -15.43% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |